| USD millions | FY2023 | FY2024 | FY2025 | FY2026 | FY2025 | FY2026 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.3 | 17.9 | 17.9 | 84.4 | 12.8 | 71.6 | +459.4% | |
| Cost of revenue | 9.2 | — | 8.4 | 115.3 | 6.0 | 88.7 | +1389.6% | |
| Gross profit | 9.1 | 10.2 | 9.5 | (22.8) | 6.8 | (22.8) | −433.3% | |
| Research & development | 5.0 | — | 3.9 | — | 3.0 | — | — | |
| Operating expenses | 24.2 | — | 20.0 | 139.7 | 20.2 | 109.1 | +440.9% | |
| Operating income | (15.1) | — | (10.5) | (55.3) | (13.3) | (37.5) | −181.4% | |
| Interest expense | 0.3 | — | 0.3 | — | 0.3 | 9.6 | +3001.3% | |
| Pre-tax income | (15.2) | — | (11.3) | (72.7) | (11.7) | (49.3) | −321.5% | |
| Income tax | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (15.2) | (11.3) | (11.3) | (11.7) | (11.7) | (50.3) | −330.3% | |
| EPS, basic (per share) | (1.10) | (8.43) | (8.43) | (0.53) | (4.91) | (0.36) | +92.7% | |
| EPS, diluted (per share) | (1.10) | (8.43) | (8.43) | (0.53) | (4.91) | (0.36) | +92.7% | |
| EBITDA | (13.4) | (8.9) | (8.9) | 25.3 | (11.8) | 22.8 | +294.4% | |
| Depreciation & amortization | 1.7 | — | 1.6 | 80.7 | 1.6 | 60.3 | +3736.0% | |
| Weighted average shares (shares) | 13,867,000 | — | 1,344,000 | 138,217,000 | 2,426,000 | 138,698,000 | +5617.1% | |
| Weighted average diluted shares (shares) | 13,867,000 | — | 20,161,000 | 138,217,000 | — | 138,698,000 | — | |
| Gross margin | 49.7% | 57.1% | 53.1% | −27.0% | 53.5% | −31.9% | −85.3 pts | |
| Operating margin | −82.7% | — | −58.4% | −65.6% | −104.1% | −52.4% | +51.8 pts | |
| Net margin | −83.1% | −63.2% | −63.2% | −13.9% | −91.4% | −70.3% | +21.1 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
